US Mandatory GRAS Notification Threatens Ingredient Innovation & Investment
The proposed shift to mandatory GRAS notification in the US, alongside new dietary guideline scrutiny, presents significant commercial and regulatory hurdles for supplement manufacturers and brand owners. Reformulation efforts are accelerating, driven by evolving consumer health demands and increased regulatory oversight.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Washington, United States — 31 August 2026
New regulatory initiatives and ongoing disputes over dietary guidance in the United States are creating a complex operational environment for supplement and food manufacturers. A proposed shift by the Department of Health and Human Services (HHS) to mandate Generally Recognized as Safe (GRAS) notifications, rather than retaining the current voluntary system, is poised to introduce considerable friction into the ingredient approval process. This move, part of a broader effort to tighten federal supervision of food ingredients and define ultra-processed foods, could significantly extend market entry timelines for novel ingredients. Critics argue mandatory notification will stifle innovation and deter investment in emerging food technologies by increasing regulatory burden and lead times.
Concurrently, the 2025 Dietary Guidelines for Americans (DGA) face legal challenge from the Physicians Committee for Responsible Medicine (PCRM). The lawsuit alleges industry influence led to alterations emphasizing meat and dairy, potentially increasing chronic disease risks. This challenges the DGA's scientific credibility and highlights the ongoing tension between public health recommendations and commercial interests. For supplement brands leveraging DGA-aligned health messaging, this litigation signals heightened scrutiny and potential shifts in consumer perception regarding dietary recommendations.
Against this backdrop, major food conglomerates like PepsiCo are accelerating reformulation efforts. Their strategy focuses on reducing sodium, sugar, and saturated fat while enhancing products with beneficial nutrients such as protein and fibre. This approach aligns with a growing industry trend towards 'benefit stacking' – developing products that deliver multiple wellness advantages simultaneously (e.g., satiety, hydration, convenience), moving away from reliance on single 'hero' ingredients. This proactive reformulation mitigates future regulatory pressure and aligns with sophisticated consumer demands for comprehensive nutritional value.
What this means for United States
US manufacturers face an immediate compliance impact from mandatory GRAS notification, necessitating budget reallocations for regulatory affairs and potentially delaying novel ingredient commercialisation by up to 18 months. Brand owners must meticulously review claims, particularly plant-based offerings, as DGA controversies could shift public sentiment and require new justification for ingredient inclusion or product positioning. This regulatory tightening presents a strategic opportunity for brands focusing on transparent, multi-benefit formulations that exceed minimum nutritional standards, offering a competitive edge against less agile competitors. Expect increased demand for GRAS-affirmed ingredients with strong scientific backing to de-risk product development.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.